Published on November 17, 2006
Exhibit
23.3
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the
Board of Directors
Novelos
Therapeutics, Inc.
We
consent to the use of our report dated March 22, 2006, except for Notes 5 and
13
for which the date is November 1, 2006, in the Registration Statement No.
333-133043 of Novelos Therapeutics, Inc. on Form SB-2 (Post-Effective Amendment
No. 1), relating to the registration of 34,285,449 shares of common stock.
We
also consent to the use of our name and the reference to us in the ‘‘Experts’’
section of this registration statement.
|
/s/
Stowe & Degon
|
|||
|
Worcester,
MA
November
16, 2006
|